← All candidates
Three insider buys in the last year — $428.8K in all.
3 filings on record.
GDTCCytoMed Therapeutics Ltd
NasdaqCM · Healthcare · $12.19M
$0.7820
+10.06% · Sep 16
Three insider buys in the last year — $428.8K in all.
Nothing in the last fortnight.
Price · 1Y · daily● 3 buys
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$12.19M
Float
3.5M
30% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
—
Price / sales
14.2
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
10% owner
Choo Chee Kong
Bought $150.0K on Jul 20 — 100,000 sh @ $1.50, held direct, 16% of their stake.
No completed positions to measure
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
Context
Wall St
$4.16 avg target
+432.0% vs today · 1 analyst · consensus Strong Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
The file stays open
3 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice